Longitudinal tumor hypoxia imaging with [(18)F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity

BACKGROUND: Non-invasive measurement of tumor hypoxia has demonstrated potential for the evaluation of disease progression, as well as prediction and assessment of treatment outcome. [(18)F]fluoroazomycin arabinoside (FAZA) positron emission tomography (PET) has been identified as a robust method fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jinzi, Klinz, Stephan G., De Souza, Raquel, Fitzgerald, Jonathan, Jaffray, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610963/
https://www.ncbi.nlm.nih.gov/pubmed/26481012
http://dx.doi.org/10.1186/s13550-015-0135-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610963/
https://www.ncbi.nlm.nih.gov/pubmed/26481012
http://dx.doi.org/10.1186/s13550-015-0135-x

Ejemplares similares